Cargando…

Serum Fc-Mediated Monocyte Phagocytosis Activity Is Stable for Several Months after SARS-CoV-2 Asymptomatic and Mildly Symptomatic Infection

We investigated the temporal profile of multiple components of the serological response after asymptomatic or mildly symptomatic SARS-CoV-2 infection, in a cohort of 67 previously SARS-CoV-2 naive young adults, up to 8.5 months after infection. We found a significant decrease of spike IgG and neutra...

Descripción completa

Detalles Bibliográficos
Autores principales: Vangeti, Sindhu, Periasamy, Sivakumar, Sun, Peifang, Balinsky, Corey A., Mahajan, Avinash S., Kuzmina, Natalia A., Soares-Schanoski, Alessandra, Cooper, Elizabeth, Beckett, Charmagne, Marayag, Jan, Marrone, Amethyst, Nunez, Edgar, Ge, Yongchao, Porter, Chad K., Goforth, Carl W., Lizewski, Stephen E., Lizewski, Rhonda, Jani, Vihasi, Sugiharto, Victor A., Schilling, Megan, Yu, Xuechen B., Marjanovic, Nada, George, Mary Catherine, Bukreyev, Alexander, Sealfon, Stuart C., Letizia, Andrew G., Ramos, Irene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9769986/
https://www.ncbi.nlm.nih.gov/pubmed/36374040
http://dx.doi.org/10.1128/spectrum.01837-22
_version_ 1784854493611950080
author Vangeti, Sindhu
Periasamy, Sivakumar
Sun, Peifang
Balinsky, Corey A.
Mahajan, Avinash S.
Kuzmina, Natalia A.
Soares-Schanoski, Alessandra
Cooper, Elizabeth
Beckett, Charmagne
Marayag, Jan
Marrone, Amethyst
Nunez, Edgar
Ge, Yongchao
Porter, Chad K.
Goforth, Carl W.
Lizewski, Stephen E.
Lizewski, Rhonda
Jani, Vihasi
Sugiharto, Victor A.
Schilling, Megan
Yu, Xuechen B.
Marjanovic, Nada
George, Mary Catherine
Bukreyev, Alexander
Sealfon, Stuart C.
Letizia, Andrew G.
Ramos, Irene
author_facet Vangeti, Sindhu
Periasamy, Sivakumar
Sun, Peifang
Balinsky, Corey A.
Mahajan, Avinash S.
Kuzmina, Natalia A.
Soares-Schanoski, Alessandra
Cooper, Elizabeth
Beckett, Charmagne
Marayag, Jan
Marrone, Amethyst
Nunez, Edgar
Ge, Yongchao
Porter, Chad K.
Goforth, Carl W.
Lizewski, Stephen E.
Lizewski, Rhonda
Jani, Vihasi
Sugiharto, Victor A.
Schilling, Megan
Yu, Xuechen B.
Marjanovic, Nada
George, Mary Catherine
Bukreyev, Alexander
Sealfon, Stuart C.
Letizia, Andrew G.
Ramos, Irene
author_sort Vangeti, Sindhu
collection PubMed
description We investigated the temporal profile of multiple components of the serological response after asymptomatic or mildly symptomatic SARS-CoV-2 infection, in a cohort of 67 previously SARS-CoV-2 naive young adults, up to 8.5 months after infection. We found a significant decrease of spike IgG and neutralization antibody titers from early (11 to 56 days) to late (4 to 8.5 months) time points postinfection. Over the study period, S1-specific IgG levels declined significantly faster than that of the S2-specific IgG. Further, serum antibodies from PCR-confirmed participants cross-recognized S2, but not S1, of the betacoronaviruses HKU1 and OC43, suggesting a greater degree of cross-reactivity of S2 among betacoronaviruses. Antibody-Dependent Natural Killer cell Activation (ADNKA) was detected at the early time point but significantly decreased at the late time point. Induction of serum Antibody-Dependent Monocyte Phagocytosis (ADMP) was detected in all the infected participants, and its levels remained stable over time. Additionally, a reduced percentage of participants had detectable neutralizing activity against the Beta (50%), Gamma (61 to 67%), and Delta (90 to 94%) variants, both early and late postinfection, compared to the ancestral strain (100%). Antibody binding to S1 and RBD of Beta, Gamma, Delta (1.7 to 2.3-fold decrease), and Omicron (10 to 16-fold decrease) variants was also significantly reduced compared to the ancestral SARS-CoV-2 strain. Overall, we found variable temporal profiles of specific components and functionality of the serological response to SARS-CoV-2 in young adults, which is characterized by lasting, but decreased, neutralizing activity and antibody binding to S1, stable ADMP activity, and relatively stable S2-specific IgG levels. IMPORTANCE Adaptive immunity mediated by antibodies is important for controlling SARS-CoV-2 infection. While vaccines against COVID-19 are currently widely distributed, a high proportion of the global population is still unvaccinated. Therefore, understanding the dynamics and maintenance of the naive humoral immune response to SARS-CoV-2 is of great importance. In addition, long-term responses after asymptomatic infection are not well-characterized, given the challenges in identifying such cases. Here, we investigated the longitudinal humoral profile in a well-characterized cohort of young adults with documented asymptomatic or mildly symptomatic SARS-CoV-2 infection. By analyzing samples collected preinfection, early after infection and during late convalescence, we found that, while neutralizing activity decreased over time, high levels of serum S2 IgG and Antibody-Dependent Monocyte Phagocytosis (ADMP) activity were maintained up to 8.5 months after infection. This suggests that a subset of antibodies with specific functions could contribute to long-term protection against SARS-CoV-2 in convalescent unvaccinated individuals.
format Online
Article
Text
id pubmed-9769986
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Society for Microbiology
record_format MEDLINE/PubMed
spelling pubmed-97699862022-12-22 Serum Fc-Mediated Monocyte Phagocytosis Activity Is Stable for Several Months after SARS-CoV-2 Asymptomatic and Mildly Symptomatic Infection Vangeti, Sindhu Periasamy, Sivakumar Sun, Peifang Balinsky, Corey A. Mahajan, Avinash S. Kuzmina, Natalia A. Soares-Schanoski, Alessandra Cooper, Elizabeth Beckett, Charmagne Marayag, Jan Marrone, Amethyst Nunez, Edgar Ge, Yongchao Porter, Chad K. Goforth, Carl W. Lizewski, Stephen E. Lizewski, Rhonda Jani, Vihasi Sugiharto, Victor A. Schilling, Megan Yu, Xuechen B. Marjanovic, Nada George, Mary Catherine Bukreyev, Alexander Sealfon, Stuart C. Letizia, Andrew G. Ramos, Irene Microbiol Spectr Research Article We investigated the temporal profile of multiple components of the serological response after asymptomatic or mildly symptomatic SARS-CoV-2 infection, in a cohort of 67 previously SARS-CoV-2 naive young adults, up to 8.5 months after infection. We found a significant decrease of spike IgG and neutralization antibody titers from early (11 to 56 days) to late (4 to 8.5 months) time points postinfection. Over the study period, S1-specific IgG levels declined significantly faster than that of the S2-specific IgG. Further, serum antibodies from PCR-confirmed participants cross-recognized S2, but not S1, of the betacoronaviruses HKU1 and OC43, suggesting a greater degree of cross-reactivity of S2 among betacoronaviruses. Antibody-Dependent Natural Killer cell Activation (ADNKA) was detected at the early time point but significantly decreased at the late time point. Induction of serum Antibody-Dependent Monocyte Phagocytosis (ADMP) was detected in all the infected participants, and its levels remained stable over time. Additionally, a reduced percentage of participants had detectable neutralizing activity against the Beta (50%), Gamma (61 to 67%), and Delta (90 to 94%) variants, both early and late postinfection, compared to the ancestral strain (100%). Antibody binding to S1 and RBD of Beta, Gamma, Delta (1.7 to 2.3-fold decrease), and Omicron (10 to 16-fold decrease) variants was also significantly reduced compared to the ancestral SARS-CoV-2 strain. Overall, we found variable temporal profiles of specific components and functionality of the serological response to SARS-CoV-2 in young adults, which is characterized by lasting, but decreased, neutralizing activity and antibody binding to S1, stable ADMP activity, and relatively stable S2-specific IgG levels. IMPORTANCE Adaptive immunity mediated by antibodies is important for controlling SARS-CoV-2 infection. While vaccines against COVID-19 are currently widely distributed, a high proportion of the global population is still unvaccinated. Therefore, understanding the dynamics and maintenance of the naive humoral immune response to SARS-CoV-2 is of great importance. In addition, long-term responses after asymptomatic infection are not well-characterized, given the challenges in identifying such cases. Here, we investigated the longitudinal humoral profile in a well-characterized cohort of young adults with documented asymptomatic or mildly symptomatic SARS-CoV-2 infection. By analyzing samples collected preinfection, early after infection and during late convalescence, we found that, while neutralizing activity decreased over time, high levels of serum S2 IgG and Antibody-Dependent Monocyte Phagocytosis (ADMP) activity were maintained up to 8.5 months after infection. This suggests that a subset of antibodies with specific functions could contribute to long-term protection against SARS-CoV-2 in convalescent unvaccinated individuals. American Society for Microbiology 2022-11-14 /pmc/articles/PMC9769986/ /pubmed/36374040 http://dx.doi.org/10.1128/spectrum.01837-22 Text en https://doi.org/10.1128/AuthorWarrantyLicense.v1This is a work of the U.S. Government and is not subject to copyright protection in the United States. Foreign copyrights may apply.
spellingShingle Research Article
Vangeti, Sindhu
Periasamy, Sivakumar
Sun, Peifang
Balinsky, Corey A.
Mahajan, Avinash S.
Kuzmina, Natalia A.
Soares-Schanoski, Alessandra
Cooper, Elizabeth
Beckett, Charmagne
Marayag, Jan
Marrone, Amethyst
Nunez, Edgar
Ge, Yongchao
Porter, Chad K.
Goforth, Carl W.
Lizewski, Stephen E.
Lizewski, Rhonda
Jani, Vihasi
Sugiharto, Victor A.
Schilling, Megan
Yu, Xuechen B.
Marjanovic, Nada
George, Mary Catherine
Bukreyev, Alexander
Sealfon, Stuart C.
Letizia, Andrew G.
Ramos, Irene
Serum Fc-Mediated Monocyte Phagocytosis Activity Is Stable for Several Months after SARS-CoV-2 Asymptomatic and Mildly Symptomatic Infection
title Serum Fc-Mediated Monocyte Phagocytosis Activity Is Stable for Several Months after SARS-CoV-2 Asymptomatic and Mildly Symptomatic Infection
title_full Serum Fc-Mediated Monocyte Phagocytosis Activity Is Stable for Several Months after SARS-CoV-2 Asymptomatic and Mildly Symptomatic Infection
title_fullStr Serum Fc-Mediated Monocyte Phagocytosis Activity Is Stable for Several Months after SARS-CoV-2 Asymptomatic and Mildly Symptomatic Infection
title_full_unstemmed Serum Fc-Mediated Monocyte Phagocytosis Activity Is Stable for Several Months after SARS-CoV-2 Asymptomatic and Mildly Symptomatic Infection
title_short Serum Fc-Mediated Monocyte Phagocytosis Activity Is Stable for Several Months after SARS-CoV-2 Asymptomatic and Mildly Symptomatic Infection
title_sort serum fc-mediated monocyte phagocytosis activity is stable for several months after sars-cov-2 asymptomatic and mildly symptomatic infection
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9769986/
https://www.ncbi.nlm.nih.gov/pubmed/36374040
http://dx.doi.org/10.1128/spectrum.01837-22
work_keys_str_mv AT vangetisindhu serumfcmediatedmonocytephagocytosisactivityisstableforseveralmonthsaftersarscov2asymptomaticandmildlysymptomaticinfection
AT periasamysivakumar serumfcmediatedmonocytephagocytosisactivityisstableforseveralmonthsaftersarscov2asymptomaticandmildlysymptomaticinfection
AT sunpeifang serumfcmediatedmonocytephagocytosisactivityisstableforseveralmonthsaftersarscov2asymptomaticandmildlysymptomaticinfection
AT balinskycoreya serumfcmediatedmonocytephagocytosisactivityisstableforseveralmonthsaftersarscov2asymptomaticandmildlysymptomaticinfection
AT mahajanavinashs serumfcmediatedmonocytephagocytosisactivityisstableforseveralmonthsaftersarscov2asymptomaticandmildlysymptomaticinfection
AT kuzminanataliaa serumfcmediatedmonocytephagocytosisactivityisstableforseveralmonthsaftersarscov2asymptomaticandmildlysymptomaticinfection
AT soaresschanoskialessandra serumfcmediatedmonocytephagocytosisactivityisstableforseveralmonthsaftersarscov2asymptomaticandmildlysymptomaticinfection
AT cooperelizabeth serumfcmediatedmonocytephagocytosisactivityisstableforseveralmonthsaftersarscov2asymptomaticandmildlysymptomaticinfection
AT beckettcharmagne serumfcmediatedmonocytephagocytosisactivityisstableforseveralmonthsaftersarscov2asymptomaticandmildlysymptomaticinfection
AT marayagjan serumfcmediatedmonocytephagocytosisactivityisstableforseveralmonthsaftersarscov2asymptomaticandmildlysymptomaticinfection
AT marroneamethyst serumfcmediatedmonocytephagocytosisactivityisstableforseveralmonthsaftersarscov2asymptomaticandmildlysymptomaticinfection
AT nunezedgar serumfcmediatedmonocytephagocytosisactivityisstableforseveralmonthsaftersarscov2asymptomaticandmildlysymptomaticinfection
AT geyongchao serumfcmediatedmonocytephagocytosisactivityisstableforseveralmonthsaftersarscov2asymptomaticandmildlysymptomaticinfection
AT porterchadk serumfcmediatedmonocytephagocytosisactivityisstableforseveralmonthsaftersarscov2asymptomaticandmildlysymptomaticinfection
AT goforthcarlw serumfcmediatedmonocytephagocytosisactivityisstableforseveralmonthsaftersarscov2asymptomaticandmildlysymptomaticinfection
AT lizewskistephene serumfcmediatedmonocytephagocytosisactivityisstableforseveralmonthsaftersarscov2asymptomaticandmildlysymptomaticinfection
AT lizewskirhonda serumfcmediatedmonocytephagocytosisactivityisstableforseveralmonthsaftersarscov2asymptomaticandmildlysymptomaticinfection
AT janivihasi serumfcmediatedmonocytephagocytosisactivityisstableforseveralmonthsaftersarscov2asymptomaticandmildlysymptomaticinfection
AT sugihartovictora serumfcmediatedmonocytephagocytosisactivityisstableforseveralmonthsaftersarscov2asymptomaticandmildlysymptomaticinfection
AT schillingmegan serumfcmediatedmonocytephagocytosisactivityisstableforseveralmonthsaftersarscov2asymptomaticandmildlysymptomaticinfection
AT yuxuechenb serumfcmediatedmonocytephagocytosisactivityisstableforseveralmonthsaftersarscov2asymptomaticandmildlysymptomaticinfection
AT marjanovicnada serumfcmediatedmonocytephagocytosisactivityisstableforseveralmonthsaftersarscov2asymptomaticandmildlysymptomaticinfection
AT georgemarycatherine serumfcmediatedmonocytephagocytosisactivityisstableforseveralmonthsaftersarscov2asymptomaticandmildlysymptomaticinfection
AT bukreyevalexander serumfcmediatedmonocytephagocytosisactivityisstableforseveralmonthsaftersarscov2asymptomaticandmildlysymptomaticinfection
AT sealfonstuartc serumfcmediatedmonocytephagocytosisactivityisstableforseveralmonthsaftersarscov2asymptomaticandmildlysymptomaticinfection
AT letiziaandrewg serumfcmediatedmonocytephagocytosisactivityisstableforseveralmonthsaftersarscov2asymptomaticandmildlysymptomaticinfection
AT ramosirene serumfcmediatedmonocytephagocytosisactivityisstableforseveralmonthsaftersarscov2asymptomaticandmildlysymptomaticinfection